The TICONC (Ticagrelor-Oncology) Study

The TICONC (Ticagrelor-Oncology) Study

Background: In cancer, platelets may facilitate metastatic spread by a number of mechanisms as well as contribute to thrombotic complications. Ticagrelor, a platelet antagonist- that blocks adenosine diphosphate activation of platelet P2Y12 receptors, is widely used in the treatment of cardiovascula...

Full description

Bibliographic Details
Main Authors: Joy R. Wright, PhD, Meera Chauhan, PhD, Chirag Shah, PhD, Alistair Ring, MD, Anne L. Thomas, PhD, Alison H. Goodall, PhD, David Adlam, DPhil
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:JACC. CardioOncology
Subjects:
aspirin
breast cancer
cancer-associated thrombotic risk
colorectal cancer
metastasis
platelets
Online Access:http://www.sciencedirect.com/science/article/pii/S2666087320300776

Internet

http://www.sciencedirect.com/science/article/pii/S2666087320300776

Similar Items